Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn’s perianal fistulas

Figure 1 Patient disposition. ¹Cohort 1: France, Germany, Spain, United Kingdom, and Canada: n = 100; Australia and Japan: n = 60; ²Cohort 2: France, n = 32; Germany, n = 17; Spain, n = 36; United Kingdom, n = 33; Canada, n = 24; Australia, n = 12; Japan, n = 20; ³Cohort 3: France, n = 18; Germany, n = 33; Spain, n = 14; United Kingdom, n = 17; Canada, n = 26; Australia, n = 17; Japan, n = 10; ⁴Patients received pharmacotherapy and/or seton placement but no PF-related surgery in the past 12 mo; ⁵With or without pharmacotherapy. CD: Crohn’s disease; CPF: Crohn’s perianal fistulas; PF: Perianal fistulas.